SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013027
Filing Date
2020-11-06
Accepted
2020-11-06 08:38:56
Documents
63
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20200930x10q.htm   iXBRL 10-Q 1327820
2 EX-31.1 imgn-20200930xex31d1.htm EX-31.1 10921
3 EX-31.2 imgn-20200930xex31d2.htm EX-31.2 10957
4 EX-32 imgn-20200930xex32.htm EX-32 10015
  Complete submission text file 0001558370-20-013027.txt   6689412

Data Files

Seq Description Document Type Size
5 EX-101.SCH imgn-20200930.xsd EX-101.SCH 53341
6 EX-101.CAL imgn-20200930_cal.xml EX-101.CAL 36955
7 EX-101.DEF imgn-20200930_def.xml EX-101.DEF 224174
8 EX-101.LAB imgn-20200930_lab.xml EX-101.LAB 495043
9 EX-101.PRE imgn-20200930_pre.xml EX-101.PRE 385308
10 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20200930x10q_htm.xml XML 1190837
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 201292535
SIC: 2834 Pharmaceutical Preparations